Patient P-01618
Synthetic patientNBL-101 · Day 115 · 55–64 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Improving
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
10%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S10
- Day 11 Trajectory diverged from prediction — Observed response fell below the model's expected path.
- Day 14 GI-04 recommended — GI Support Protocol GI-04
- Day 15 Patient accepted — Started GI-04 in the companion
- Day 23 GI symptom burden −17% vs expected — GI Support Protocol GI-04
- Day 29 Tolerance state changed — Unstable → Improving
What changed?
Trajectory began diverging from predicted response on Day 11.
Primary contributors, last 14 days
- Toxicity-4
- GI instability+2
- Treatment adherence+2
What helped?
- GI Support Protocol GI-04Day 14Result: symptom burden −17%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion10/100
improving · -5.6 vs previous 14 d
Toxicity
Blood20.2/100
stable · -0.7 vs previous 14 d
Sleep quality
Wearable76.2/100
improving · +3.3 vs previous 14 d
Energy level
Daily log7/10
stable · +0.0 vs previous 14 d
Stress level
Daily log3/10
improving · -0.5 vs previous 14 d
Steps
Wearable3,123
improving · +351 vs previous 14 d
Adherence
Companion94.9 %
stable · -0.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 78 from the failing basin, 40 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
Would not help
- Keep fat lowGI +6.4 next day on high-intake days · n 25
- Keep histamine lowGI +6.1 next day on high-intake days · n 19
- Keep simple carbs lowGI +4.2 next day on high-intake days · n 19
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Dietary fat load+6.4detractor · 95%
- Histamine load+6.1detractor · 95%
- Simple carbohydrates+4.2detractor · 95%
- Insoluble fibre+1.2no signal · 23%
- Alcohol+0.5no signal · 15%
- Spicy / capsaicin+0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓35
- MicrobiomeButyrate capacity 44/100
- Mucosal barrier integrity ↓30
- DNAFUT2 non-secretor lowers mucosal fucosylation
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
- Autonomic recovery ↓20
- Wearable3,123 steps/day
DNA
Fictional pharmacogenomic panel
- FUT2 rs601338 AA (non-secretor)Reduced mucosal fucosylation
- CYP2D6 Normal metabolizerExpected exposure
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 1.9 · butyrate capacity 44/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 67 ms
- Sleep
- 7.7 h
- Steps
- 3,487
- Resting HR
- 67 bpm
Daily log: GI score 10, nutritional resilience 69, adherence 95.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.